| Not Yet Recruiting | Electrocautery Resection Combined With HITHOC for Thymic Epithelial Tumors With Pleural Metastasis NCT07328074 | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | — |
| Recruiting | Tislelizumab Combined With Anlotinib as Second-line Therapy in Thymoma and Thymic Carcinoma NCT06838910 | The First Affiliated Hospital with Nanjing Medical University | Phase 2 |
| Recruiting | Glucocorticoids Combined With Concurrent Chemoradiotherapy for Unresectable Thymoma NCT06730308 | Sun Yat-sen University | Phase 2 |
| Recruiting | Hypofractionated Radiotherapy for Thymic Epithelial Tumors NCT06692062 | Rongrong Zhou | N/A |
| Recruiting | A Phase II Trial of Sacituzumab Govitecan in Patients With Advanced Thymic Epithelial Tumors NCT06248515 | Georgetown University | Phase 2 |
| Recruiting | Robot-assisted vs VATS for Thymoma NCT06029621 | Shanghai Pulmonary Hospital, Shanghai, China | N/A |
| Recruiting | Artificial Intelligence Prediction Tool in Thymic Epithelial Tumors NCT06301945 | Erasmus Medical Center | — |
| Unknown | Application of 68Ga-Pentixafor PET/CT for Thymoma NCT06086327 | Peking Union Medical College Hospital | EARLY_Phase 1 |
| Completed | IL-8+ naïve T Cells as a Biomarker for Thymoma Identification NCT05255965 | Shanghai Zhongshan Hospital | — |
| Unknown | Folinic Acid for Prevention of Pemetrexed-induced Toxicity NCT06010277 | Amphia Hospital | Phase 4 |
| Active Not Recruiting | Clinical Investigation of the da Vinci Surgical System NCT05682742 | Intuitive Surgical | N/A |
| Unknown | A Prospective, Single-Center Investigation of the da Vinci SP® Surgical System in Anterior Mediastinal Disease NCT05455840 | Chang Gung Memorial Hospital | N/A |
| Active Not Recruiting | SP Thoracic IDE Study NCT05150210 | Intuitive Surgical | N/A |
| Unknown | Comparison of Single Port and Two Ports Robotic Assisted Thoracic Surgery for Thymectomy NCT05262582 | Shanghai Pulmonary Hospital, Shanghai, China | N/A |
| Recruiting | Predictors and Prognostic Factors of Myasthenia Gravis Outcome NCT05214612 | Assiut University | — |
| Completed | Surgery for Masaoka-Koga I-II Thymoma NCT05001113 | Shanghai Zhongshan Hospital | N/A |
| Terminated | Cardiac Rehabilitation for Patients Receiving Radiation Therapy for Thoracic Cancers NCT04072393 | Washington University School of Medicine | N/A |
| Unknown | Single Cell Sequencing Analysis of Thymoma NCT04162691 | Zhejiang Cancer Hospital | — |
| Completed | 177Lu-DOTA-TATE and Olaparib in Somatostatin Receptor Positive Tumours NCT04375267 | Vastra Gotaland Region | Phase 1 |
| Completed | Bosutinib in Combination With Pemetrexed in Patients With Selected Metastatic Solid Tumors NCT03023319 | Nagla Abdel Karim | Phase 1 |
| Unknown | Ramucirumab and Carbo-Paclitaxel for Untreated Thymic Carcinoma / B3 Thymoma With Carcinoma (RELEVENT) NCT03921671 | Claudia Proto | Phase 2 |
| Completed | A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors NCT03517488 | Xencor, Inc. | Phase 1 |
| Unknown | The Curative Effect of Extended Thymectomy Performed Through Subxiphoid-right VATS Approach With Elevation of NCT03613272 | Jiang Fan | N/A |
| Terminated | Selinexor in Patients With Advanced Thymic Epithelial Tumor Progressing After Primary Chemotherapy NCT03193437 | Georgetown University | Phase 2 |
| Recruiting | Adjuvant Radiotherapy for Stage II/III Thymoma After Complete Resection NCT02633553 | Fudan University | N/A |
| Unknown | Selinexor in Patients With Advanced Thymoma and Thymic Carcinoma NCT03466827 | Morten Mau-Soerensen | Phase 2 |
| Unknown | Confocal Laser Endomicroscopy in Pleural Malignancies NCT03290183 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | — |
| Active Not Recruiting | A Pilot Study to Investigate the Safety and Clinical Activity of Avelumab (MSB0010718C) in Thymoma and Thymic NCT03076554 | National Cancer Institute (NCI) | Phase 2 |
| Withdrawn | Regulation of LncRNA For Breg in Patients With Thymoma and Autoimmune Diseases NCT02948855 | Tianjin Medical University Cancer Institute and Hospital | — |
| Unknown | Abscopal Effect of Radiotherapy in Combination With rhGM-CSF for Advanced Thymic Epithelial Tumours NCT05407649 | Shanghai Cancer Hospital, China | Phase 2 |
| Completed | A Study of BKM120 (Buparlisib) in Relapsed or Refractory Thymomas NCT02220855 | Patrick Joseph Loehrer Sr. | Phase 2 |
| Terminated | Doxepin Hydrochloride in Treating Esophageal Pain in Patients With Thoracic Cancer Receiving Radiation Therapy NCT02062632 | Mayo Clinic | Phase 2 |
| Completed | Relationship Between Computed Tomography Manifestation and Histopathological Classification of Thymic Epitheli NCT03288662 | Military Hospital 103 | N/A |
| Recruiting | Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma NCT01950572 | National Cancer Institute (NCI) | — |
| Unknown | Postoperative Conformal Radiotherapy for Stage II-III B Type Thymoma NCT02014805 | Chinese Academy of Medical Sciences | Phase 3 |
| Completed | Sunitinib for Advanced Thymus Cancer Following Earlier Treatment NCT01621568 | National Cancer Institute (NCI) | Phase 2 |
| Enrolling By Invitation | Molecular Analysis of Thoracic Malignancies NCT01385722 | Stanford University | — |
| Active Not Recruiting | An Investigational Scan (MRI) in Imaging Patients With Newly-Diagnosed or Recurrent Thymoma NCT03968315 | M.D. Anderson Cancer Center | N/A |
| Completed | A Phase 2 Study of Amrubicin in Relapsed or Refractory Thymic Malignancies NCT01364727 | Heather Wakelee | Phase 2 |
| Terminated | Tumor Cell Vaccines With ISCOMATRIX Adjuvant and Celecoxib in Patients Undergoing Resection of Lung and Esopha NCT01258868 | National Cancer Institute (NCI) | Phase 1 |
| Unknown | Intravenous Palifosfamide-tris in Combination With Etoposide and Carboplatin in Patients With Malignancies NCT01242072 | Alaunos Therapeutics | Phase 1 |
| Terminated | A Phase 1/2 Study of PXD101 (Belinostat) in Combination With Cisplatin, Doxorubicin and Cyclophosphamide in th NCT01100944 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Active Not Recruiting | Chemotherapy Plus Cetuximab Followed by Surgical Resection in Patients With Locally Advanced or Recurrent Thym NCT01025089 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Completed | Esophageal Sparing Intensity-modulated Radiation Therapy (IMRT) for Locally-Advanced Thoracic Malignancies NCT00921739 | Duke University | Phase 1 |
| Completed | Multicenter Phase II Study of IMC-A12 in Patients With Thymoma and Thymic Carcinoma Who Have Been Previously T NCT00965250 | National Cancer Institute (NCI) | Phase 2 |
| Terminated | Paclitaxel and Cisplatin for Thymic Neoplasm NCT00818090 | Korean Cancer Study Group | Phase 2 |
| Completed | Biology of Thymic Tumors NCT00965627 | Istituto Clinico Humanitas | — |
| Completed | Belinostat (PXD101) to Treat Tumors of the Thymus at an Advanced Stage NCT00589290 | National Cancer Institute (NCI) | Phase 2 |
| Completed | The Role of the Thymus in Myasthenia Gravis NCT01102192 | Charite University, Berlin, Germany | — |
| Completed | Preoperative Treatment of Patients With High Risk Thymoma NCT00387868 | Valley Health System | Phase 2 |
| Completed | A Study to Test the Safety and Efficacy of Erlotinib Plus Bevacizumab to Treat Advanced Thymoma and Thymic Can NCT00369889 | Indiana University School of Medicine | Phase 2 |
| Completed | Efficacy of Octreotide Treatment in Patients With Primary Inoperable Thymoma NCT00332969 | Novartis Pharmaceuticals | Phase 2 |
| Completed | Phase II Study of Alimta (Pemetrexed) Treatment of Advanced Thymoma and Thymic Carcinoma NCT00198133 | Patrick Joseph Loehrer Sr. | Phase 2 |
| Completed | Prospective Study of Stereotactic Body Radiation Therapy for Thymoma Inoma: Therapeutic Effect and Toxicity As NCT03078699 | Third Military Medical University | N/A |
| Completed | Prognostic Factors in Patients Submitted to Surgical Treatment for Thymoma NCT04577495 | IRCCS San Raffaele | — |
| Completed | Nonmyeloablative Allogeneic Transplant NCT01272817 | Scripps Health | N/A |
| Completed | Carboplatin Combined With Paclitaxel in Treating Patients With Advanced Thymoma NCT00010257 | Eastern Cooperative Oncology Group | Phase 2 |